PUBLISHER: KBV Research | PRODUCT CODE: 1384958
PUBLISHER: KBV Research | PRODUCT CODE: 1384958
North America Non-invasive Prenatal Testing (NIPT) Market Size, Share & Industry Trends Analysis Report By Product, By Application, By End User (Diagnostic Laboratories, Hospitals & Clinics), By Technology, By Country and Growth Forecast, 2023 - 2030
The North America Non-invasive Prenatal Testing (NIPT) Market would witness market growth of 17.4% CAGR during the forecast period (2023-2030).
One notable trend in the market is the continuous expansion of the test menu. Initially focused on common chromosomal abnormalities, NIPT is now increasingly capable of detecting a wider range of conditions, including microdeletions and rare genetic disorders. Advances in genetic sequencing and bioinformatics drive this expansion of capabilities. The market has seen substantial growth in market size and revenue. The increasing demand for NIPT services and the development of new applications have fuelled the market's expansion.
NIPT is increasingly becoming accessible in emerging markets owing to partnerships between diagnostic companies and local healthcare providers. This trend is improving the availability of NIPT to a broader demographic. Integrating artificial intelligence (AI) and machine learning in NIPT data analysis is becoming more prevalent. These technologies enhance the accuracy of results and enable more precise detection of abnormalities. Some NIPT providers offer consumer-initiated testing, allowing pregnant individuals to request and pay for NIPT without needing a healthcare provider's prescription. This trend empowers individuals to take control of their prenatal care.
In North America, access to prenatal care can vary based on geographic location, socioeconomic status, and insurance coverage. Efforts are made to improve access, particularly for vulnerable populations. According to the data released by the U.S. Department of Health and Human Services (HHS), through the Health Resources and Services Administration (HRSA), 35 HRSA-funded health institutions received more than $65 million from the Government to address maternal mortality cases. Therefore, rising prenatal care investment in North America will boost the region's demand for non-invasive prenatal testing.
The US market dominated the North America Non-invasive Prenatal Testing (NIPT) Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $5,133.9 Million by 2030. The Canada market is experiencing a CAGR of 20.1% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 19% during (2023 - 2030).
Based on Product, the market is segmented into Consumables & Reagents, and Instruments. Based on Application, the market is segmented into Trisomy, Microdeletion Syndrome, and Others. Based on End User, the market is segmented into Diagnostic Laboratories, Hospitals & Clinics. Based on Technology, the market is segmented into Next Generation Sequencing (NGS), Microarray, Polymerase Chain Reaction (PCR), and Rolling Circular Amplification. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Illumina, Inc., Natera Inc., F. Hoffmann-La Roche Ltd., PerkinElmer, Inc., Laboratory Corporation of America Holdings, Eurofins Scientific SE, Thermo Fisher Scientific, Inc., GE HealthCare Technologies, Inc., Agilent Technologies, Inc., and Pacific Biosciences of California, Inc.
Scope of the Study
Market Segments covered in the Report:
By Product
- Consumables & Reagents
- Instruments
By Application
- Trisomy
- Microdeletion Syndrome
- Others
By End User
- Diagnostic Laboratories
- Hospitals & Clinics
By Technology
- Next Generation Sequencing (NGS)
- Microarray
- Polymerase Chain Reaction (PCR)
- Rolling Circular Amplification
By Country
- US
- Canada
- Mexico
- Rest of North America
Companies Profiled
- Illumina, Inc.
- Natera Inc.
- F. Hoffmann-La Roche Ltd.
- PerkinElmer, Inc.
- Laboratory Corporation of America Holdings
- Eurofins Scientific SE
- Thermo Fisher Scientific, Inc.
- GE HealthCare Technologies, Inc.
- Agilent Technologies, Inc.
- Pacific Biosciences of California, Inc.
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 North America Non-invasive Prenatal Testing (NIPT) Market, by Product
- 1.4.2 North America Non-invasive Prenatal Testing (NIPT) Market, by Application
- 1.4.3 North America Non-invasive Prenatal Testing (NIPT) Market, by End User
- 1.4.4 North America Non-invasive Prenatal Testing (NIPT) Market, by Technology
- 1.4.5 North America Non-invasive Prenatal Testing (NIPT) Market, by Country
- 1.5 Methodology for the research
Chapter 2. Market at a Glance
- 2.1 Key Highlights
Chapter 3. Market Overview
- 3.1 Introduction
- 3.1.1 Overview
- 3.1.1.1 Market Composition and Scenario
- 3.1.1 Overview
- 3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.3 Porter Five Forces Analysis
Chapter 4. North America Non-invasive Prenatal Testing (NIPT) Market by Product
- 4.1 North America Consumables & Reagents Market by Region
- 4.2 North America Instruments Market by Region
Chapter 5. North America Non-invasive Prenatal Testing (NIPT) Market by Application
- 5.1 North America Trisomy Market by Country
- 5.2 North America Microdeletion Syndrome Market by Country
- 5.3 North America Others Market by Country
Chapter 6. North America Non-invasive Prenatal Testing (NIPT) Market by End User
- 6.1 North America Diagnostic Laboratories Market by Country
- 6.2 North America Hospitals & Clinics Market by Country
Chapter 7. North America Non-invasive Prenatal Testing (NIPT) Market by Technology
- 7.1 North America Next Generation Sequencing (NGS) Market by Country
- 7.2 North America Microarray Market by Country
- 7.3 North America Polymerase Chain Reaction (PCR) Market by Country
- 7.4 North America Rolling Circular Amplification Market by Country
Chapter 8. North America Non-invasive Prenatal Testing (NIPT) Market by Country
- 8.1 US Non-invasive Prenatal Testing (NIPT) Market
- 8.1.1 US Non-invasive Prenatal Testing (NIPT) Market by Product
- 8.1.2 US Non-invasive Prenatal Testing (NIPT) Market by Application
- 8.1.3 US Non-invasive Prenatal Testing (NIPT) Market by End User
- 8.1.4 US Non-invasive Prenatal Testing (NIPT) Market by Technology
- 8.2 Canada Non-invasive Prenatal Testing (NIPT) Market
- 8.2.1 Canada Non-invasive Prenatal Testing (NIPT) Market by Product
- 8.2.2 Canada Non-invasive Prenatal Testing (NIPT) Market by Application
- 8.2.3 Canada Non-invasive Prenatal Testing (NIPT) Market by End User
- 8.2.4 Canada Non-invasive Prenatal Testing (NIPT) Market by Technology
- 8.3 Mexico Non-invasive Prenatal Testing (NIPT) Market
- 8.3.1 Mexico Non-invasive Prenatal Testing (NIPT) Market by Product
- 8.3.2 Mexico Non-invasive Prenatal Testing (NIPT) Market by Application
- 8.3.3 Mexico Non-invasive Prenatal Testing (NIPT) Market by End User
- 8.3.4 Mexico Non-invasive Prenatal Testing (NIPT) Market by Technology
- 8.4 Rest of North America Non-invasive Prenatal Testing (NIPT) Market
- 8.4.1 Rest of North America Non-invasive Prenatal Testing (NIPT) Market by Product
- 8.4.2 Rest of North America Non-invasive Prenatal Testing (NIPT) Market by Application
- 8.4.3 Rest of North America Non-invasive Prenatal Testing (NIPT) Market by End User
- 8.4.4 Rest of North America Non-invasive Prenatal Testing (NIPT) Market by Technology
Chapter 9. Company Profiles
- 9.1 Illumina, Inc.
- 9.1.1 Company Overview
- 9.1.2 Financial Analysis
- 9.1.3 Regional Analysis
- 9.1.4 Research & Development Expense
- 9.1.5 Recent strategies and developments:
- 9.1.5.1 Partnerships, Collaborations, and Agreements:
- 9.1.5.2 Acquisition and Mergers:
- 9.1.6 SWOT Analysis
- 9.2 Natera Inc.
- 9.2.1 Company Overview
- 9.2.2 Financial Analysis
- 9.2.3 Regional Analysis
- 9.2.4 Research & Development Expenses
- 9.2.5 SWOT Analysis
- 9.3 F. Hoffmann-La Roche Ltd.
- 9.3.1 Company Overview
- 9.3.2 Financial Analysis
- 9.3.3 Segmental and Regional Analysis
- 9.3.4 Research & Development Expense
- 9.3.5 SWOT Analysis
- 9.4 PerkinElmer, Inc.
- 9.4.1 Company Overview
- 9.4.2 Financial Analysis
- 9.4.3 Segmental and Regional Analysis
- 9.4.4 Research & Development Expense
- 9.4.5 Recent strategies and developments:
- 9.4.5.1 Acquisition and Mergers:
- 9.4.6 SWOT Analysis
- 9.5 Laboratory Corporation of America Holdings
- 9.5.1 Company Overview
- 9.5.2 Financial Analysis
- 9.5.3 Segmental Analysis
- 9.5.4 SWOT Analysis
- 9.6 Eurofins Scientific SE
- 9.6.1 Company Overview
- 9.6.2 Financial Analysis
- 9.6.3 Regional Analysis
- 9.6.4 Recent strategies and developments:
- 9.6.4.1 Product Launches and Product Expansions:
- 9.6.5 SWOT Analysis
- 9.7 Thermo Fisher Scientific, Inc.
- 9.7.1 Company Overview
- 9.7.2 Financial Analysis
- 9.7.3 Segmental and Regional Analysis
- 9.7.4 Research & Development Expenses
- 9.7.5 WOT Analysis
- 9.8 GE HealthCare Technologies, Inc.
- 9.8.1 Company Overview
- 9.8.2 Financial Analysis
- 9.8.3 Segmental and Regional Analysis
- 9.8.4 Research & Development Expenses
- 9.8.5 Recent strategies and developments:
- 9.8.5.1 Product Launches and Product Expansions:
- 9.8.5.2 Acquisition and Mergers:
- 9.8.6 SWOT Analysis
- 9.9 Agilent Technologies, Inc.
- 9.9.1 Company Overview
- 9.9.2 Financial Analysis
- 9.9.3 Segmental and Regional Analysis
- 9.9.4 Research & Development Expense
- 9.9.5 SWOT Analysis
- 9.10. Pacific Biosciences of California, Inc.
- 9.10.1 Company Overview
- 9.10.2 Financial Analysis
- 9.10.3 Regional Analysis
- 9.10.4 Research & Development Expenses
- 9.10.5 Recent strategies and developments:
- 9.10.5.1 Acquisition and Mergers:
- 9.10.6 SWOT Analysis
LIST OF TABLES
- TABLE 1 North America Non-invasive Prenatal Testing (NIPT) Market, 2019 - 2022, USD Million
- TABLE 2 North America Non-invasive Prenatal Testing (NIPT) Market, 2023 - 2030, USD Million
- TABLE 3 North America Non-invasive Prenatal Testing (NIPT) Market by Product, 2019 - 2022, USD Million
- TABLE 4 North America Non-invasive Prenatal Testing (NIPT) Market by Product, 2023 - 2030, USD Million
- TABLE 5 North America Consumables & Reagents Market by Region, 2019 - 2022, USD Million
- TABLE 6 North America Consumables & Reagents Market by Region, 2023 - 2030, USD Million
- TABLE 7 North America Instruments Market by Region, 2019 - 2022, USD Million
- TABLE 8 North America Instruments Market by Region, 2023 - 2030, USD Million
- TABLE 9 North America Non-invasive Prenatal Testing (NIPT) Market by Application, 2019 - 2022, USD Million
- TABLE 10 North America Non-invasive Prenatal Testing (NIPT) Market by Application, 2023 - 2030, USD Million
- TABLE 11 North America Trisomy Market by Country, 2019 - 2022, USD Million
- TABLE 12 North America Trisomy Market by Country, 2023 - 2030, USD Million
- TABLE 13 North America Microdeletion Syndrome Market by Country, 2019 - 2022, USD Million
- TABLE 14 North America Microdeletion Syndrome Market by Country, 2023 - 2030, USD Million
- TABLE 15 North America Others Market by Country, 2019 - 2022, USD Million
- TABLE 16 North America Others Market by Country, 2023 - 2030, USD Million
- TABLE 17 North America Non-invasive Prenatal Testing (NIPT) Market by End User, 2019 - 2022, USD Million
- TABLE 18 North America Non-invasive Prenatal Testing (NIPT) Market by End User, 2023 - 2030, USD Million
- TABLE 19 North America Diagnostic Laboratories Market by Country, 2019 - 2022, USD Million
- TABLE 20 North America Diagnostic Laboratories Market by Country, 2023 - 2030, USD Million
- TABLE 21 North America Hospitals & Clinics Market by Country, 2019 - 2022, USD Million
- TABLE 22 North America Hospitals & Clinics Market by Country, 2023 - 2030, USD Million
- TABLE 23 North America Non-invasive Prenatal Testing (NIPT) Market by Technology, 2019 - 2022, USD Million
- TABLE 24 North America Non-invasive Prenatal Testing (NIPT) Market by Technology, 2023 - 2030, USD Million
- TABLE 25 North America Next Generation Sequencing (NGS) Market by Country, 2019 - 2022, USD Million
- TABLE 26 North America Next Generation Sequencing (NGS) Market by Country, 2023 - 2030, USD Million
- TABLE 27 North America Microarray Market by Country, 2019 - 2022, USD Million
- TABLE 28 North America Microarray Market by Country, 2023 - 2030, USD Million
- TABLE 29 North America Polymerase Chain Reaction (PCR) Market by Country, 2019 - 2022, USD Million
- TABLE 30 North America Polymerase Chain Reaction (PCR) Market by Country, 2023 - 2030, USD Million
- TABLE 31 North America Rolling Circular Amplification Market by Country, 2019 - 2022, USD Million
- TABLE 32 North America Rolling Circular Amplification Market by Country, 2023 - 2030, USD Million
- TABLE 33 North America Non-invasive Prenatal Testing (NIPT) Market by Country, 2019 - 2022, USD Million
- TABLE 34 North America Non-invasive Prenatal Testing (NIPT) Market by Country, 2023 - 2030, USD Million
- TABLE 35 US Non-invasive Prenatal Testing (NIPT) Market, 2019 - 2022, USD Million
- TABLE 36 US Non-invasive Prenatal Testing (NIPT) Market, 2023 - 2030, USD Million
- TABLE 37 US Non-invasive Prenatal Testing (NIPT) Market by Product, 2019 - 2022, USD Million
- TABLE 38 US Non-invasive Prenatal Testing (NIPT) Market by Product, 2023 - 2030, USD Million
- TABLE 39 US Non-invasive Prenatal Testing (NIPT) Market by Application, 2019 - 2022, USD Million
- TABLE 40 US Non-invasive Prenatal Testing (NIPT) Market by Application, 2023 - 2030, USD Million
- TABLE 41 US Non-invasive Prenatal Testing (NIPT) Market by End User, 2019 - 2022, USD Million
- TABLE 42 US Non-invasive Prenatal Testing (NIPT) Market by End User, 2023 - 2030, USD Million
- TABLE 43 US Non-invasive Prenatal Testing (NIPT) Market by Technology, 2019 - 2022, USD Million
- TABLE 44 US Non-invasive Prenatal Testing (NIPT) Market by Technology, 2023 - 2030, USD Million
- TABLE 45 Canada Non-invasive Prenatal Testing (NIPT) Market, 2019 - 2022, USD Million
- TABLE 46 Canada Non-invasive Prenatal Testing (NIPT) Market, 2023 - 2030, USD Million
- TABLE 47 Canada Non-invasive Prenatal Testing (NIPT) Market by Product, 2019 - 2022, USD Million
- TABLE 48 Canada Non-invasive Prenatal Testing (NIPT) Market by Product, 2023 - 2030, USD Million
- TABLE 49 Canada Non-invasive Prenatal Testing (NIPT) Market by Application, 2019 - 2022, USD Million
- TABLE 50 Canada Non-invasive Prenatal Testing (NIPT) Market by Application, 2023 - 2030, USD Million
- TABLE 51 Canada Non-invasive Prenatal Testing (NIPT) Market by End User, 2019 - 2022, USD Million
- TABLE 52 Canada Non-invasive Prenatal Testing (NIPT) Market by End User, 2023 - 2030, USD Million
- TABLE 53 Canada Non-invasive Prenatal Testing (NIPT) Market by Technology, 2019 - 2022, USD Million
- TABLE 54 Canada Non-invasive Prenatal Testing (NIPT) Market by Technology, 2023 - 2030, USD Million
- TABLE 55 Mexico Non-invasive Prenatal Testing (NIPT) Market, 2019 - 2022, USD Million
- TABLE 56 Mexico Non-invasive Prenatal Testing (NIPT) Market, 2023 - 2030, USD Million
- TABLE 57 Mexico Non-invasive Prenatal Testing (NIPT) Market by Product, 2019 - 2022, USD Million
- TABLE 58 Mexico Non-invasive Prenatal Testing (NIPT) Market by Product, 2023 - 2030, USD Million
- TABLE 59 Mexico Non-invasive Prenatal Testing (NIPT) Market by Application, 2019 - 2022, USD Million
- TABLE 60 Mexico Non-invasive Prenatal Testing (NIPT) Market by Application, 2023 - 2030, USD Million
- TABLE 61 Mexico Non-invasive Prenatal Testing (NIPT) Market by End User, 2019 - 2022, USD Million
- TABLE 62 Mexico Non-invasive Prenatal Testing (NIPT) Market by End User, 2023 - 2030, USD Million
- TABLE 63 Mexico Non-invasive Prenatal Testing (NIPT) Market by Technology, 2019 - 2022, USD Million
- TABLE 64 Mexico Non-invasive Prenatal Testing (NIPT) Market by Technology, 2023 - 2030, USD Million
- TABLE 65 Rest of North America Non-invasive Prenatal Testing (NIPT) Market, 2019 - 2022, USD Million
- TABLE 66 Rest of North America Non-invasive Prenatal Testing (NIPT) Market, 2023 - 2030, USD Million
- TABLE 67 Rest of North America Non-invasive Prenatal Testing (NIPT) Market by Product, 2019 - 2022, USD Million
- TABLE 68 Rest of North America Non-invasive Prenatal Testing (NIPT) Market by Product, 2023 - 2030, USD Million
- TABLE 69 Rest of North America Non-invasive Prenatal Testing (NIPT) Market by Application, 2019 - 2022, USD Million
- TABLE 70 Rest of North America Non-invasive Prenatal Testing (NIPT) Market by Application, 2023 - 2030, USD Million
- TABLE 71 Rest of North America Non-invasive Prenatal Testing (NIPT) Market by End User, 2019 - 2022, USD Million
- TABLE 72 Rest of North America Non-invasive Prenatal Testing (NIPT) Market by End User, 2023 - 2030, USD Million
- TABLE 73 Rest of North America Non-invasive Prenatal Testing (NIPT) Market by Technology, 2019 - 2022, USD Million
- TABLE 74 Rest of North America Non-invasive Prenatal Testing (NIPT) Market by Technology, 2023 - 2030, USD Million
- TABLE 75 key information - Illumina, Inc.
- TABLE 76 Key Information - Natera Inc.
- TABLE 77 Key Information - F. Hoffmann-La Roche Ltd.
- TABLE 78 key Information - PerkinElmer, Inc.
- TABLE 79 Key Information - Laboratory Corporation of America holdings
- TABLE 80 Key Information - Eurofins Scientific SE
- TABLE 81 Key Information - Thermo Fisher Scientific, Inc.
- TABLE 82 Key Information - GE HealthCare Technologies, Inc.
- TABLE 83 key Information - Agilent Technologies, Inc.
- TABLE 84 Key Information - Pacific Biosciences of California, Inc.
